nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—SST—Mecp2 and Associated Rett Syndrome—BCL6—lymphatic system cancer	0.058	0.665	CbGpPWpGaD
Cysteamine—Skin striae—Bleomycin—lymphatic system cancer	0.0325	0.0356	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—PROX1—lymphatic system cancer	0.0292	0.335	CbGpPWpGaD
Cysteamine—Gastrointestinal ulcer—Methotrexate—lymphatic system cancer	0.027	0.0296	CcSEcCtD
Cysteamine—Optic neuritis—Fludarabine—lymphatic system cancer	0.0229	0.0251	CcSEcCtD
Cysteamine—Gastrointestinal ulcer haemorrhage—Methotrexate—lymphatic system cancer	0.0218	0.0239	CcSEcCtD
Cysteamine—Encephalopathy—Carmustine—lymphatic system cancer	0.0141	0.0154	CcSEcCtD
Cysteamine—Hepatic function abnormal—Teniposide—lymphatic system cancer	0.0133	0.0146	CcSEcCtD
Cysteamine—Scotoma—Carmustine—lymphatic system cancer	0.0119	0.013	CcSEcCtD
Cysteamine—Liver function test abnormal—Teniposide—lymphatic system cancer	0.0108	0.0118	CcSEcCtD
Cysteamine—Thinking abnormal—Carmustine—lymphatic system cancer	0.00987	0.0108	CcSEcCtD
Cysteamine—Dehydration—Fludarabine—lymphatic system cancer	0.00953	0.0104	CcSEcCtD
Cysteamine—Liver function test abnormal—Fludarabine—lymphatic system cancer	0.00946	0.0104	CcSEcCtD
Cysteamine—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00852	0.00934	CcSEcCtD
Cysteamine—Appetite absent—Methotrexate—lymphatic system cancer	0.00841	0.00921	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00805	0.00882	CcSEcCtD
Cysteamine—Mental disability—Carmustine—lymphatic system cancer	0.00784	0.00859	CcSEcCtD
Cysteamine—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00777	0.00851	CcSEcCtD
Cysteamine—Renal failure—Fludarabine—lymphatic system cancer	0.00776	0.0085	CcSEcCtD
Cysteamine—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00755	0.00827	CcSEcCtD
Cysteamine—Anorexia—Mechlorethamine—lymphatic system cancer	0.00741	0.00811	CcSEcCtD
Cysteamine—Eye pain—Carmustine—lymphatic system cancer	0.00726	0.00796	CcSEcCtD
Cysteamine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00676	0.0074	CcSEcCtD
Cysteamine—Encephalopathy—Methotrexate—lymphatic system cancer	0.00652	0.00714	CcSEcCtD
Cysteamine—Anaemia—Teniposide—lymphatic system cancer	0.00649	0.00711	CcSEcCtD
Cysteamine—Agitation—Teniposide—lymphatic system cancer	0.00645	0.00707	CcSEcCtD
Cysteamine—Leukopenia—Teniposide—lymphatic system cancer	0.00628	0.00688	CcSEcCtD
Cysteamine—Pain in extremity—Vincristine—lymphatic system cancer	0.00626	0.00686	CcSEcCtD
Cysteamine—Malnutrition—Fludarabine—lymphatic system cancer	0.00617	0.00676	CcSEcCtD
Cysteamine—Ataxia—Carmustine—lymphatic system cancer	0.00617	0.00675	CcSEcCtD
Cysteamine—Hypertension—Teniposide—lymphatic system cancer	0.00606	0.00664	CcSEcCtD
Cysteamine—Liver function test abnormal—Carmustine—lymphatic system cancer	0.00605	0.00663	CcSEcCtD
Cysteamine—Ataxia—Vincristine—lymphatic system cancer	0.00589	0.00645	CcSEcCtD
Cysteamine—Dehydration—Vincristine—lymphatic system cancer	0.00582	0.00638	CcSEcCtD
Cysteamine—Confusional state—Teniposide—lymphatic system cancer	0.00578	0.00633	CcSEcCtD
Cysteamine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00573	0.00627	CcSEcCtD
Cysteamine—Anaemia—Fludarabine—lymphatic system cancer	0.0057	0.00625	CcSEcCtD
Cysteamine—Agitation—Fludarabine—lymphatic system cancer	0.00567	0.00621	CcSEcCtD
Cysteamine—Dehydration—Mitoxantrone—lymphatic system cancer	0.00567	0.00621	CcSEcCtD
Cysteamine—Leukopenia—Fludarabine—lymphatic system cancer	0.00552	0.00605	CcSEcCtD
Cysteamine—Anorexia—Teniposide—lymphatic system cancer	0.00546	0.00598	CcSEcCtD
Cysteamine—Convulsion—Fludarabine—lymphatic system cancer	0.00535	0.00586	CcSEcCtD
Cysteamine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00532	0.00582	CcSEcCtD
Cysteamine—Discomfort—Fludarabine—lymphatic system cancer	0.00519	0.00568	CcSEcCtD
Cysteamine—Confusional state—Fludarabine—lymphatic system cancer	0.00508	0.00556	CcSEcCtD
Cysteamine—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00504	0.00552	CcSEcCtD
Cysteamine—Decreased appetite—Teniposide—lymphatic system cancer	0.00498	0.00546	CcSEcCtD
Cysteamine—Renal failure—Carmustine—lymphatic system cancer	0.00497	0.00544	CcSEcCtD
Cysteamine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00494	0.00541	CcSEcCtD
Cysteamine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00494	0.00541	CcSEcCtD
Cysteamine—Rash—Mechlorethamine—lymphatic system cancer	0.0049	0.00537	CcSEcCtD
Cysteamine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0049	0.00536	CcSEcCtD
Cysteamine—Anorexia—Fludarabine—lymphatic system cancer	0.0048	0.00526	CcSEcCtD
Cysteamine—Feeling abnormal—Teniposide—lymphatic system cancer	0.00472	0.00517	CcSEcCtD
Cysteamine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00468	0.00513	CcSEcCtD
Cysteamine—Bone disorder—Methotrexate—lymphatic system cancer	0.00463	0.00507	CcSEcCtD
Cysteamine—Renal failure—Mitoxantrone—lymphatic system cancer	0.00462	0.00506	CcSEcCtD
Cysteamine—Nausea—Mechlorethamine—lymphatic system cancer	0.00462	0.00506	CcSEcCtD
Cysteamine—Urticaria—Teniposide—lymphatic system cancer	0.00455	0.00499	CcSEcCtD
Cysteamine—Abdominal pain—Teniposide—lymphatic system cancer	0.00453	0.00496	CcSEcCtD
Cysteamine—Body temperature increased—Teniposide—lymphatic system cancer	0.00453	0.00496	CcSEcCtD
Cysteamine—Erythema—Bleomycin—lymphatic system cancer	0.00452	0.00496	CcSEcCtD
Cysteamine—Hallucination—Carmustine—lymphatic system cancer	0.00451	0.00494	CcSEcCtD
Cysteamine—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00446	0.00488	CcSEcCtD
Cysteamine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00443	0.00486	CcSEcCtD
Cysteamine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00438	0.00479	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00435	0.00476	CcSEcCtD
Cysteamine—Fatigue—Fludarabine—lymphatic system cancer	0.00434	0.00476	CcSEcCtD
Cysteamine—Hallucination—Vincristine—lymphatic system cancer	0.00431	0.00472	CcSEcCtD
Cysteamine—Constipation—Fludarabine—lymphatic system cancer	0.00431	0.00472	CcSEcCtD
Cysteamine—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00428	0.00468	CcSEcCtD
Cysteamine—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00426	0.00466	CcSEcCtD
Cysteamine—Urethral disorder—Vincristine—lymphatic system cancer	0.00424	0.00465	CcSEcCtD
Cysteamine—Hypersensitivity—Teniposide—lymphatic system cancer	0.00422	0.00462	CcSEcCtD
Cysteamine—Anaemia—Bleomycin—lymphatic system cancer	0.00418	0.00458	CcSEcCtD
Cysteamine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00415	0.00455	CcSEcCtD
Cysteamine—Asthenia—Teniposide—lymphatic system cancer	0.00411	0.0045	CcSEcCtD
Cysteamine—Leukopenia—Bleomycin—lymphatic system cancer	0.00405	0.00444	CcSEcCtD
Cysteamine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00398	0.00436	CcSEcCtD
Cysteamine—Mental disorder—Carmustine—lymphatic system cancer	0.00397	0.00435	CcSEcCtD
Cysteamine—Malnutrition—Carmustine—lymphatic system cancer	0.00395	0.00433	CcSEcCtD
Cysteamine—Erythema—Carmustine—lymphatic system cancer	0.00395	0.00433	CcSEcCtD
Cysteamine—Diarrhoea—Teniposide—lymphatic system cancer	0.00392	0.00429	CcSEcCtD
Cysteamine—Discomfort—Bleomycin—lymphatic system cancer	0.00381	0.00417	CcSEcCtD
Cysteamine—Mental disorder—Vincristine—lymphatic system cancer	0.00379	0.00416	CcSEcCtD
Cysteamine—Confusional state—Bleomycin—lymphatic system cancer	0.00372	0.00408	CcSEcCtD
Cysteamine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00371	0.00406	CcSEcCtD
Cysteamine—Tremor—Carmustine—lymphatic system cancer	0.0037	0.00405	CcSEcCtD
Cysteamine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00369	0.00404	CcSEcCtD
Cysteamine—Erythema—Mitoxantrone—lymphatic system cancer	0.00367	0.00402	CcSEcCtD
Cysteamine—Anaemia—Carmustine—lymphatic system cancer	0.00365	0.004	CcSEcCtD
Cysteamine—Vomiting—Teniposide—lymphatic system cancer	0.00364	0.00399	CcSEcCtD
Cysteamine—Agitation—Carmustine—lymphatic system cancer	0.00363	0.00397	CcSEcCtD
Cysteamine—Asthenia—Fludarabine—lymphatic system cancer	0.00361	0.00396	CcSEcCtD
Cysteamine—Rash—Teniposide—lymphatic system cancer	0.00361	0.00396	CcSEcCtD
Cysteamine—Dermatitis—Teniposide—lymphatic system cancer	0.00361	0.00395	CcSEcCtD
Cysteamine—Headache—Teniposide—lymphatic system cancer	0.00359	0.00393	CcSEcCtD
Cysteamine—Leukopenia—Carmustine—lymphatic system cancer	0.00353	0.00387	CcSEcCtD
Cysteamine—Anorexia—Bleomycin—lymphatic system cancer	0.00352	0.00385	CcSEcCtD
Cysteamine—Anaemia—Vincristine—lymphatic system cancer	0.00348	0.00382	CcSEcCtD
Cysteamine—Agitation—Vincristine—lymphatic system cancer	0.00346	0.00379	CcSEcCtD
Cysteamine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00345	0.00377	CcSEcCtD
Cysteamine—Convulsion—Carmustine—lymphatic system cancer	0.00342	0.00375	CcSEcCtD
Cysteamine—Hypertension—Carmustine—lymphatic system cancer	0.00341	0.00373	CcSEcCtD
Cysteamine—Nausea—Teniposide—lymphatic system cancer	0.0034	0.00373	CcSEcCtD
Cysteamine—Anaemia—Mitoxantrone—lymphatic system cancer	0.00339	0.00372	CcSEcCtD
Cysteamine—Leukopenia—Vincristine—lymphatic system cancer	0.00337	0.0037	CcSEcCtD
Cysteamine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00329	0.0036	CcSEcCtD
Cysteamine—Convulsion—Vincristine—lymphatic system cancer	0.00327	0.00358	CcSEcCtD
Cysteamine—Hypertension—Vincristine—lymphatic system cancer	0.00325	0.00356	CcSEcCtD
Cysteamine—Confusional state—Carmustine—lymphatic system cancer	0.00325	0.00356	CcSEcCtD
Cysteamine—Decreased appetite—Bleomycin—lymphatic system cancer	0.00321	0.00352	CcSEcCtD
Cysteamine—Vomiting—Fludarabine—lymphatic system cancer	0.0032	0.00351	CcSEcCtD
Cysteamine—Convulsion—Mitoxantrone—lymphatic system cancer	0.00318	0.00348	CcSEcCtD
Cysteamine—Rash—Fludarabine—lymphatic system cancer	0.00317	0.00348	CcSEcCtD
Cysteamine—Dermatitis—Fludarabine—lymphatic system cancer	0.00317	0.00347	CcSEcCtD
Cysteamine—Hypertension—Mitoxantrone—lymphatic system cancer	0.00317	0.00347	CcSEcCtD
Cysteamine—Headache—Fludarabine—lymphatic system cancer	0.00315	0.00346	CcSEcCtD
Cysteamine—Lethargy—Methotrexate—lymphatic system cancer	0.0031	0.00339	CcSEcCtD
Cysteamine—Discomfort—Mitoxantrone—lymphatic system cancer	0.00309	0.00338	CcSEcCtD
Cysteamine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00308	0.00337	CcSEcCtD
Cysteamine—Anorexia—Carmustine—lymphatic system cancer	0.00307	0.00336	CcSEcCtD
Cysteamine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00304	0.00333	CcSEcCtD
Cysteamine—Confusional state—Mitoxantrone—lymphatic system cancer	0.00302	0.00331	CcSEcCtD
Cysteamine—Nervous system disorder—Vincristine—lymphatic system cancer	0.00302	0.0033	CcSEcCtD
Cysteamine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.003	0.00328	CcSEcCtD
Cysteamine—Nausea—Fludarabine—lymphatic system cancer	0.00299	0.00328	CcSEcCtD
Cysteamine—Urticaria—Bleomycin—lymphatic system cancer	0.00293	0.00321	CcSEcCtD
Cysteamine—Anorexia—Vincristine—lymphatic system cancer	0.00293	0.00321	CcSEcCtD
Cysteamine—Body temperature increased—Bleomycin—lymphatic system cancer	0.00292	0.0032	CcSEcCtD
Cysteamine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00291	0.00319	CcSEcCtD
Cysteamine—Mood swings—Methotrexate—lymphatic system cancer	0.00288	0.00315	CcSEcCtD
Cysteamine—Somnolence—Carmustine—lymphatic system cancer	0.00286	0.00314	CcSEcCtD
Cysteamine—Anorexia—Mitoxantrone—lymphatic system cancer	0.00286	0.00313	CcSEcCtD
Cysteamine—Ataxia—Methotrexate—lymphatic system cancer	0.00286	0.00313	CcSEcCtD
Cysteamine—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.0028	0.00307	CcSEcCtD
Cysteamine—Decreased appetite—Carmustine—lymphatic system cancer	0.0028	0.00307	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00278	0.00305	CcSEcCtD
Cysteamine—Constipation—Carmustine—lymphatic system cancer	0.00276	0.00302	CcSEcCtD
Cysteamine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00272	0.00298	CcSEcCtD
Cysteamine—Decreased appetite—Vincristine—lymphatic system cancer	0.00267	0.00293	CcSEcCtD
Cysteamine—Somnolence—Mitoxantrone—lymphatic system cancer	0.00266	0.00292	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00266	0.00291	CcSEcCtD
Cysteamine—Feeling abnormal—Carmustine—lymphatic system cancer	0.00266	0.00291	CcSEcCtD
Cysteamine—Fatigue—Vincristine—lymphatic system cancer	0.00265	0.00291	CcSEcCtD
Cysteamine—Asthenia—Bleomycin—lymphatic system cancer	0.00265	0.0029	CcSEcCtD
Cysteamine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00264	0.00289	CcSEcCtD
Cysteamine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00264	0.00289	CcSEcCtD
Cysteamine—Constipation—Vincristine—lymphatic system cancer	0.00263	0.00288	CcSEcCtD
Cysteamine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.0026	0.00285	CcSEcCtD
Cysteamine—Fatigue—Mitoxantrone—lymphatic system cancer	0.00258	0.00283	CcSEcCtD
Cysteamine—Constipation—Mitoxantrone—lymphatic system cancer	0.00256	0.00281	CcSEcCtD
Cysteamine—Body temperature increased—Carmustine—lymphatic system cancer	0.00255	0.00279	CcSEcCtD
Cysteamine—Abdominal pain—Carmustine—lymphatic system cancer	0.00255	0.00279	CcSEcCtD
Cysteamine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00252	0.00276	CcSEcCtD
Cysteamine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00247	0.0027	CcSEcCtD
Cysteamine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00245	0.00268	CcSEcCtD
Cysteamine—Body temperature increased—Vincristine—lymphatic system cancer	0.00243	0.00266	CcSEcCtD
Cysteamine—Abdominal pain—Vincristine—lymphatic system cancer	0.00243	0.00266	CcSEcCtD
Cysteamine—Urticaria—Mitoxantrone—lymphatic system cancer	0.00238	0.00261	CcSEcCtD
Cysteamine—Hypersensitivity—Carmustine—lymphatic system cancer	0.00237	0.0026	CcSEcCtD
Cysteamine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00237	0.00259	CcSEcCtD
Cysteamine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00237	0.00259	CcSEcCtD
Cysteamine—Vomiting—Bleomycin—lymphatic system cancer	0.00235	0.00257	CcSEcCtD
Cysteamine—Rash—Bleomycin—lymphatic system cancer	0.00233	0.00255	CcSEcCtD
Cysteamine—Dermatitis—Bleomycin—lymphatic system cancer	0.00233	0.00255	CcSEcCtD
Cysteamine—Asthenia—Carmustine—lymphatic system cancer	0.00231	0.00253	CcSEcCtD
Cysteamine—Renal failure—Methotrexate—lymphatic system cancer	0.0023	0.00252	CcSEcCtD
Cysteamine—Hypersensitivity—Vincristine—lymphatic system cancer	0.00227	0.00248	CcSEcCtD
Cysteamine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00221	0.00242	CcSEcCtD
Cysteamine—Asthenia—Vincristine—lymphatic system cancer	0.00221	0.00242	CcSEcCtD
Cysteamine—Diarrhoea—Carmustine—lymphatic system cancer	0.0022	0.00242	CcSEcCtD
Cysteamine—Nausea—Bleomycin—lymphatic system cancer	0.00219	0.0024	CcSEcCtD
Cysteamine—Asthenia—Mitoxantrone—lymphatic system cancer	0.00215	0.00235	CcSEcCtD
Cysteamine—Dizziness—Carmustine—lymphatic system cancer	0.00213	0.00233	CcSEcCtD
Cysteamine—Diarrhoea—Vincristine—lymphatic system cancer	0.0021	0.00231	CcSEcCtD
Cysteamine—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00207	0.00227	CcSEcCtD
Cysteamine—Urethral disorder—Methotrexate—lymphatic system cancer	0.00206	0.00226	CcSEcCtD
Cysteamine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00205	0.00225	CcSEcCtD
Cysteamine—Vomiting—Carmustine—lymphatic system cancer	0.00205	0.00224	CcSEcCtD
Cysteamine—Dizziness—Vincristine—lymphatic system cancer	0.00203	0.00223	CcSEcCtD
Cysteamine—Rash—Carmustine—lymphatic system cancer	0.00203	0.00223	CcSEcCtD
Cysteamine—Dermatitis—Carmustine—lymphatic system cancer	0.00203	0.00222	CcSEcCtD
Cysteamine—Headache—Carmustine—lymphatic system cancer	0.00202	0.00221	CcSEcCtD
Cysteamine—Vomiting—Vincristine—lymphatic system cancer	0.00196	0.00214	CcSEcCtD
Cysteamine—Rash—Vincristine—lymphatic system cancer	0.00194	0.00212	CcSEcCtD
Cysteamine—Dermatitis—Vincristine—lymphatic system cancer	0.00194	0.00212	CcSEcCtD
Cysteamine—Headache—Vincristine—lymphatic system cancer	0.00193	0.00211	CcSEcCtD
Cysteamine—Nausea—Carmustine—lymphatic system cancer	0.00191	0.0021	CcSEcCtD
Cysteamine—Vomiting—Mitoxantrone—lymphatic system cancer	0.0019	0.00209	CcSEcCtD
Cysteamine—Immune system disorder—Methotrexate—lymphatic system cancer	0.0019	0.00208	CcSEcCtD
Cysteamine—Rash—Mitoxantrone—lymphatic system cancer	0.00189	0.00207	CcSEcCtD
Cysteamine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00189	0.00207	CcSEcCtD
Cysteamine—Headache—Mitoxantrone—lymphatic system cancer	0.00188	0.00206	CcSEcCtD
Cysteamine—Mental disorder—Methotrexate—lymphatic system cancer	0.00184	0.00202	CcSEcCtD
Cysteamine—Erythema—Methotrexate—lymphatic system cancer	0.00183	0.002	CcSEcCtD
Cysteamine—Malnutrition—Methotrexate—lymphatic system cancer	0.00183	0.002	CcSEcCtD
Cysteamine—Nausea—Vincristine—lymphatic system cancer	0.00183	0.002	CcSEcCtD
Cysteamine—Nausea—Mitoxantrone—lymphatic system cancer	0.00178	0.00195	CcSEcCtD
Cysteamine—Anaemia—Methotrexate—lymphatic system cancer	0.00169	0.00185	CcSEcCtD
Cysteamine—Leukopenia—Methotrexate—lymphatic system cancer	0.00164	0.00179	CcSEcCtD
Cysteamine—Convulsion—Methotrexate—lymphatic system cancer	0.00158	0.00174	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00155	0.00169	CcSEcCtD
Cysteamine—Discomfort—Methotrexate—lymphatic system cancer	0.00154	0.00169	CcSEcCtD
Cysteamine—Confusional state—Methotrexate—lymphatic system cancer	0.00151	0.00165	CcSEcCtD
Cysteamine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00149	0.00164	CcSEcCtD
Cysteamine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00146	0.0016	CcSEcCtD
Cysteamine—Skin disorder—Methotrexate—lymphatic system cancer	0.00145	0.00159	CcSEcCtD
Cysteamine—Anorexia—Methotrexate—lymphatic system cancer	0.00142	0.00156	CcSEcCtD
Cysteamine—Somnolence—Methotrexate—lymphatic system cancer	0.00133	0.00145	CcSEcCtD
Cysteamine—Dyspepsia—Methotrexate—lymphatic system cancer	0.00131	0.00144	CcSEcCtD
Cysteamine—Decreased appetite—Methotrexate—lymphatic system cancer	0.0013	0.00142	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00129	0.00141	CcSEcCtD
Cysteamine—Fatigue—Methotrexate—lymphatic system cancer	0.00129	0.00141	CcSEcCtD
Cysteamine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00123	0.00135	CcSEcCtD
Cysteamine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00122	0.00134	CcSEcCtD
Cysteamine—Urticaria—Methotrexate—lymphatic system cancer	0.00119	0.0013	CcSEcCtD
Cysteamine—Abdominal pain—Methotrexate—lymphatic system cancer	0.00118	0.00129	CcSEcCtD
Cysteamine—Body temperature increased—Methotrexate—lymphatic system cancer	0.00118	0.00129	CcSEcCtD
Cysteamine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.0011	0.0012	CcSEcCtD
Cysteamine—Asthenia—Methotrexate—lymphatic system cancer	0.00107	0.00117	CcSEcCtD
Cysteamine—Diarrhoea—Methotrexate—lymphatic system cancer	0.00102	0.00112	CcSEcCtD
Cysteamine—Dizziness—Methotrexate—lymphatic system cancer	0.000987	0.00108	CcSEcCtD
Cysteamine—Vomiting—Methotrexate—lymphatic system cancer	0.000949	0.00104	CcSEcCtD
Cysteamine—Rash—Methotrexate—lymphatic system cancer	0.000941	0.00103	CcSEcCtD
Cysteamine—Dermatitis—Methotrexate—lymphatic system cancer	0.00094	0.00103	CcSEcCtD
Cysteamine—Headache—Methotrexate—lymphatic system cancer	0.000935	0.00102	CcSEcCtD
Cysteamine—Nausea—Methotrexate—lymphatic system cancer	0.000887	0.000971	CcSEcCtD
